What is EndoSim?
EndoSim is a research-oriented company committed to enhancing the skills of endoscopists through rigorous, practice-based training. Leveraging ex-vivo specimens that offer a realistic simulation environment, EndoSim's methodology is validated in major endoscopy journals. The company's training programs are designed to improve procedural success rates, as evidenced by research indicating a reduction in perforation percentages. Key procedural areas include ESD/EMR, Hemostasis, and others, with training courses available upon direct inquiry.
How much funding has EndoSim raised?
EndoSim has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
What's next for EndoSim?
With the recent infusion of expansion capital, EndoSim is poised for significant growth. The substantial backing at this Series B/C stage suggests a strategic focus on scaling operations, potentially expanding product development, and increasing market reach. This investment will likely fuel further research and development, reinforcing EndoSim's position as a leader in medical simulation and skills training for critical endoscopic procedures. The company's trajectory indicates a strong commitment to advancing medical education through innovative, data-driven solutions.
See full EndoSim company page
